| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $61.59B | +21.9% |
| Cost of Revenue | $41.89B | +22.6% |
| R&D Expense | $1.12B | +0.4% |
| SG&A Expense | $4.23B | +22.3% |
| Operating Income | $9.37B | +22.9% |
| Interest Expense | $47.3M | -20.5% |
| Pre-tax Income | $9.20B | +18.5% |
| Income Tax | $2.21B | +24.7% |
| Net Income | $6.88B |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.89B | -3.4% |
| Short-term Investments | $4.0M | -7.5% |
| Accounts Receivable | $10.48B | +19.2% |
| Current Assets | $21.61B | +9.9% |
| Total Assets | $47.26B | +9.5% |
| Current Liabilities | $17.52B | +11.6% |
| Long-term Debt | $45.9M | -14.2% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.54B | +6.3% |
| Capital Expenditures | $718.0M | +23.8% |
| Investing Cash Flow | -$4.26B | +1.1% |
| Financing Cash Flow | -$5.31B | -7.8% |
| Free Cash Flow | $8.82B | +5.1% |
| +16.4% |
| EPS (Basic) | $10.87 | +16.8% |
| EPS (Diluted) | $10.71 | +16.9% |
| Stockholders' Equity |
| $22.11B |
| +13.2% |